AbCellera Biologics Inc. ABCL Income taxes receivable
Income taxes receivable at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxesReceivable.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s income taxes receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s income taxes receivable?
- AbCellera Biologics Inc. (ABCL) reported income taxes receivable of $39.8M in Q1 2026.
- How has AbCellera Biologics Inc.'s income taxes receivable changed year-over-year?
- AbCellera Biologics Inc.'s income taxes receivable increased by 73.0% year-over-year, from $23M to $39.8M.
- What is the long-term trend for AbCellera Biologics Inc.'s income taxes receivable?
- Over 3 years (2022 to 2025), AbCellera Biologics Inc.'s income taxes receivable has grown at a -4.9% compound annual growth rate (CAGR), from $64.82M to $55.7M.
- What does income taxes receivable mean?
- Income tax refunds or overpayments expected from tax authorities, including estimated tax prepayments in excess of actual liability.